Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICUCW) Invested Capital (2023 - 2025)

SeaStar Medical Holding's Invested Capital history spans 3 years, with the latest figure at $10.4 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 584.51% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $10.4 million, up 584.51%, while the annual FY2025 figure was $10.4 million, 584.51% up from the prior year.
  • Invested Capital reached $10.4 million in Q4 2025 per ICUCW's latest filing, down from $11.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $11.5 million in Q3 2025 to a low of -$21.0 million in Q1 2023.
  • Average Invested Capital over 3 years is -$3.2 million, with a median of -$2.7 million recorded in 2024.
  • Peak YoY movement for Invested Capital: rose 27.56% in 2024, then surged 558823.2% in 2025.
  • A 3-year view of Invested Capital shows it stood at -$9.7 million in 2023, then skyrocketed by 77.81% to -$2.2 million in 2024, then soared by 584.51% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Invested Capital are $10.4 million (Q4 2025), $11.5 million (Q3 2025), and $3.3 million (Q2 2025).